Theravance Biopharma Inc. (TBPH) slipped -5.34% or -1.5 to $26.6. It is nearly 23362 shares traded, which is 9.16% compare to the average total volume 255052. The market cap of TBPH is $1.47 billion. The year to date change is -5.23%. The 52 week price range is from $21.27 to $35.48. Price of TBPH have changed 2.52% during last week. It have changed 9.72% over last month, -0.95% over last 3 months, 18.12% over last 6 months and 4.27% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for TBPH is 27.60. It is 3.76% above current price. The 200-day Moving Averages for TBPH is 26.23. It is -1.39% below current price. The 52-week High is 35.48. It is 33.38% from the current price. The 52-week Low is 21.27. It is -20.04% from current price.
There are some statistics of TBPH. It is has market cap $1.47 billion. The share outstanding is 55.41 million. The average volume is 255052. The percent of top 15 Institution holding is 144.80%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of TBPH is -295.61%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of TBPH is -58.86%.